We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Onzima Ventures | LSE:ONZ | London | Ordinary Share | GB00BYQCDH57 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.25 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
14/6/2016 09:43 | Shares in sticky hands . Onwards and upwards from here. | sophisticatedtrader | |
14/6/2016 09:29 | I'd be surprised if the directors have had their lot. They too will want to buy the dips imo | jakleeds | |
14/6/2016 09:26 | Good move jack - imo. | someuwin | |
14/6/2016 09:26 | This stock is so getting pumped and flipped. There is a good case and business model. And I will be topping up on further dips lining the flippers pockets for a medium term hold but the relentless buying has no real effect on share price but one 6 figure sell and they tick it down. Typical pattern for a high availability of stock. It will take news to get this moving or the overhang to get sold off. | phil1969 | |
14/6/2016 09:24 | Ok got another lot so just over half a million now. Will sit and wait and see.... | jakleeds | |
14/6/2016 09:14 | well done Jakleeds. Very volatile today. Expect the market makers are looking for opportunities, feel they sold stock they dont own over the last few days, trying to get those back today, cheaper. | keya5000 | |
14/6/2016 09:12 | Well I've picked up just under half a million this morning easily. | jakleeds | |
14/6/2016 09:08 | Zak Mir @ZaksTradersCaf Tip TV Single Stocks: June 14 2016 #AFPO #CTAG #GAL #HMI #HNR #FUM #ONZ: via @YouTube | someuwin | |
14/6/2016 08:56 | I am unable to even buy a grands worth at the moment with Barclays :) | ihavenoclue | |
14/6/2016 08:04 | Break of 2p leads a clear path to gap above 2.5p. Chart offer little resistance. | keya5000 | |
14/6/2016 07:53 | Should see 2p+ very soon - imo. | someuwin | |
13/6/2016 22:55 | Walloon3, You can tell the organ grinder that this is just the start. | fido | |
13/6/2016 22:15 | Walloon3, Go on then, I give up. What is it like or is that too complicated a question for you. | fido | |
13/6/2016 16:20 | Phil, think the majority went to the likes of Mcnulty/Theobald in the recent placing. Cannot see them moving them on soon. But you always get some who want a quick turn. | keya5000 | |
13/6/2016 16:17 | Need to see the back of the short termers flipping the 15m placing. | phil1969 | |
13/6/2016 16:12 | someuwin. Yes been watching the volume. Given the N4/NT stake, ex UTN NED, Mcnulty there are not many to go around. I reckon 80-90m are tightly held. That's not a lot at these levels cash wise to take a significant amount of the remainder. Another day plus 20m by 4.30? | keya5000 | |
13/6/2016 16:09 | V. High volume again. About 7% of the company changed hands today. | someuwin | |
13/6/2016 15:34 | "...In humans the nano-carrier can be deployed as a slow release mechanism for vaccines for diseases such as hepatitis B. Here in the UK we rarely hear about cases of Hep-B because we receive injections from a young age to guard against it. In the developing world it is a problem. Because the drug is given in three jabs it is a logistical nightmare to administer, particularly where the population is either isolated or nomadic. A single injection would likely prove a far more elegant and effective solution, Theobald pointed out. Again, N4 will look to license out this pre-clinical innovation, which has also been adapted for use in the emerging field of immuno-onocology where the body’s immune system is used to fight cancer." | someuwin | |
13/6/2016 14:53 | OXP had a mcap well in excess of £120m at its peak, NT thinks he can do better with N4. Makes ONZ a compelling buy. | keya5000 | |
13/6/2016 14:50 | Bought a few more today. | someuwin | |
13/6/2016 13:53 | ONZ is valued at less than some empty shell companies. Yet as well as their trading portfolio of resource stocks they have a 49% share of a private pharma company which has multiple potential blockbuster products and a CEO who has proved himself and the business concept with LSE:OXP. | someuwin | |
13/6/2016 13:07 | Phil I think the N4 investment sets it above MTR. | keya5000 | |
13/6/2016 12:53 | How similar would you rate ONZ to MTR ONZ mcap £3m, MTR mcap £20m (has been as high as £33m) Maybe a slight overhang as some (but not all) of the placing shares get flipped but the buying seems pretty relentless. | phil1969 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions